Confluence Labs

foundation models optimized for learning efficiency

Winter 2026ActiveB2BArtificial IntelligenceAISan Francisco, CA, USA

Company

While modern AI excels in any area you can collect a lot of data for, it struggles in areas where data is sparse or costly to attain. Designing new molecules, discovering new physics, and engineering new materials, and even developing more effective systems of governance are all domains where collecting data is extremely costly. We dream of a world where AI accelerates research in all of these domains and creates a more abundant future for humanity, but the current technology is not there. That’s why we started Confluence Labs. We are building AI that can design highly effective experiments in data-sparse domains and learn maximally from the data it already has.

Verdict

High Signal

Market Opportunity

The target applications — drug design, hardware engineering, materials science, physics research — are multi-billion dollar markets where data efficiency is a genuine bottleneck. B2B enterprise customers in pharma, biotech, and semiconductors routinely spend heavily on R&D acceleration tools. The ICP (researchers gated by cost of physical experiments) is clear and well-articulated.

Low Signal

Founder Signal

Niranjan Baskaran is a Vassar '27 / Dartmouth '28 student — effectively a current undergrad with ~0 industry experience beyond a 1-month contract gig at Whop doing React Native UI work and some research assistant roles. Brent Burdick is a self-described college dropout and self-taught engineer with no LinkedIn data available to verify any claims. Impressive hackathon wins and RSI/ISEF participation show raw intellect, but this team has essentially no professional track record shipping production AI systems or working in the target domains (drug design, materials science, physics research).

Medium Signal

Competition

They're competing against frontier labs (Anthropic, OpenAI, Google DeepMind) on reasoning benchmarks, which is a David vs. Goliath situation. In the scientific AI application space, competitors include Recursion Pharmaceuticals, Insilico Medicine, Exscientia, and Benchling for specific verticals, plus general AI labs pivoting to scientific applications. Their differentiation — LLM-driven program synthesis for data-sparse domains — is technically interesting but not yet a proven moat since it's built on top of existing LLMs (GPT, Claude) rather than proprietary model weights.

Medium Signal

Product

The company claims SOTA on ARC-AGI-2 at 97.9% accuracy for $11.77/task, beating Claude Opus 4.6 Thinking and GPT 5.2 Thinking High on the public eval. They've open-sourced their solver, which is reproducible — this is a real technical result, not vaporware. However, there are no paying customers, no revenue, no API docs, no pricing page, and the actual product (hypothesis generation + data-efficient modeling for drug/hardware/physics) is described as aspirational and future-looking.

OverallC Tier

Confluence Labs has a genuinely impressive technical result — SOTA on ARC-AGI-2 is a real signal of research capability, not marketing fluff — but the gap between 'we beat a benchmark' and 'we have a business' is enormous here. The team is essentially two undergrads/dropouts with no professional experience in the target domains (drug design, materials science, physics) and no enterprise sales experience, which is a serious liability for a B2B play targeting research institutions and pharma companies. The product is currently a benchmark solver and an open-source repo, not a commercial offering. Backed by YC and Paul Graham, which provides credibility and runway, but this is very early research-stage with no customers, no revenue, and a long road to monetization in extremely complex enterprise verticals.

Active Founders

Niranjan Baskaran

Founder

Training models by allowing knowledge to compound

Brent Burdick

Founder

I'm a college drop out and self-taught engineer and researcher.

Confluence Labs

TierC Tier

BatchWinter 2026

Team Size2

StatusActive

LocationSan Francisco, CA, USA